6:36 pm 6:36 pm

A mass sterilization exercise: Kenyan doctors find anti-fertility agent in UN tetanus vaccine

November 10th, 2014|Authorities Speak Out, blog, Tetanus Vaccine Risk|

Kenya’s Catholic bishops are charging two United Nations organizations with sterilizing millions of girls and women under cover of an anti-tetanus inoculation program sponsored by the Kenyan government.

According to a statement released Tuesday by the Kenya Catholic Doctors Association, the organization has found an antigen that causes miscarriages in a vaccine being administered to 2.3 million girls and women by the World Health Organization and UNICEF. Priests throughout Kenya reportedly are advising their congregations to refuse the vaccine.

“We sent six samples from around Kenya to laboratories in South Africa. They tested positive for the HCG antigen,” Dr. Muhame Ngare of the Mercy Medical Centre in Nairobi told LifeSiteNews. “They were all laced with HCG.”

Dr. Ngare, spokesman for the Kenya Catholic Doctors Association, stated in a bulletin released November 4, “This proved right our worst fears; that this WHO campaign is not about eradicating neonatal tetanus but a well-coordinated forceful population control mass sterilization exercise using a proven fertility regulating vaccine. This evidence was presented to the Ministry of Health before the third round of immunization but was ignored.”

But the government says the vaccine is safe. Health Minister James Macharia even told the BBC, “I would recommend my own daughter and wife to take it because I entirely 100% agree with it and have confidence it has no adverse health effects.”

And Dr. Collins Tabu, head of the Health Ministry’s immunization branch, told the Kenyan Nation, that “there is no other additive in the vaccine other than the tetanus antigen.”

Tabu said the

1:13 pm 1:13 pm

Adacel Vaccine Corporate Safety Information

March 15th, 2014|Diptheria Vaccine Ineffectiveness, Diptheria Vaccine Risk, Pertussis (Whooping Cough) Vaccine Ineffectiveness, Pertussis (Whooping Cough) Vaccine Risk, Tetanus Vaccine Ineffectiveness, Tetanus Vaccine Risk, Vaccine Ineffectiveness, Vaccine Risks|


Adacel vaccine is indicated for active booster immunization for the prevention of tetanus, diphtheria, and pertussis as a single dose in persons 11 through 64 years of age.

The most common local and systemic adverse reactions to Adacel vaccine include injection site pain, erythema, and swelling; headache, body ache, tiredness, and fever. Other adverse reactions may occur. A severe allergic reaction after a previous dose of Adacel vaccine or any other tetanus toxoid, diphtheria toxoid or pertussis containing vaccine, or to any component, or encephalopathy within 7 days of a previous dose of a pertussis containing vaccine, is a contraindication.

The decision to give Adacel vaccine should be based on the potential benefits and risks; especially if Guillain-Barré syndrome has occurred within 6 weeks of receipt of a prior vaccine containing tetanus toxoid; if progressive or unstable neurologic disorders exist; or if adverse events have occurred in temporal relation to receipt of pertussis-containing vaccine. Persons who experienced Arthus-type hypersensitivity reactions following a prior dose of tetanus toxoid-containing vaccine should not receive Adacel vaccine less than 10 years since the last dose of tetanus toxoid-containing vaccine. The tip caps of the prefilled syringes may contain natural rubber latex, which may cause allergic reactions in latex sensitive individuals. Vaccination with Adacel vaccine may not protect all individuals.

Before administering Adacel vaccine, please click here to read full Prescribing Information.

Adacel vaccine is manufactured by Sanofi Pasteur Limited and distributed by Sanofi Pasteur Inc.



adacel approved age 7